Novavax Will Ask Global Regulators to Clear the First Protein-based Covid-19 Vaccine for ... - Latest Tweet by Bloomberg

Novavax will ask global regulators to clear the first protein-based Covid-19 vaccine for use in teens ages 12 to 17 after a trial showed it prevented symptomatic cases https://t.co/kGBitnE0bQ— Bloomberg (@business) February 10, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)